HispanicBusiness

Our objective is not to actively enter any specific marketplace, but to license our technology to partners, who have developed the considerable expertise necessary sell, deploy and operate in this sector and others. If you are offering any remote monitoring or data generating technology let us see how we can work together to improve the services you are offering.

Gary Campbell, President

Contact:
Mr. Gary Campbell, President
Direct 702 900 7022
Office 702 253 7499
Website: Cytta.com
info@cytta.com

Appendix A Pilot Program Whitepaper

Biometric remote telemonitoring to produce a healthy return on investment, decrease resource utilization, and improve care coordination

By Terry Olson, MD
August 30, 2012

Background

A large full risk, capitated medical group located in Southern California with employed and IPA physicians completed a six (6) month trial to determine if high cost patients not well managed in traditional care coordination programs and traditional healthcare delivery systems can decrease cost of care and improve patient satisfaction through remote telemonitoring using the CYTTA Connect Ecosystem and an intense case management process. Costs were realized in savings from:

•Hospital admissions

•Emergency Room Visits

•Urgent Care Visits

•Specialty Visits



Methodology

Twenty-seven (27) patients were identified through claims analysis with frequent use of primary care and specialty visits, Emergency Room visits, Urgent Care visits, Hospital admissions, two (2) or more co-morbidities, and little to no adherence to their current medical treatment plan. After further review, twenty (20) patients were enrolled in to this remote telemonitoring program trial. Resource utilization for the 180 days prior to enrollment in this pilot program was compared to monthly resource utilization during this trial. Patient and Provider satisfaction surveys were sent and interviews were completed with patients, care coordination staff, and physician providers who utilized the telemonitoring technology to determine their satisfaction with the program and case management. Recommendations were formulated at the completion of the trial.

This was a voluntary program which allowed patients to disenroll at any point during the trial. Patients who agreed to participate in the trial completed a 30 minute office orientation session to introduce the telemonitoring products and review the care coordination program. CYTTA provided technical resources, consultation to maintain device performance and all materials and services at no cost. All HIPPA requirements were incorporated into program design and care coordination processes.

Patients participated in the trial from their home after completing the orientation session. Technology performance issues were resolved remotely and within the patient's home for 4 patients. Biometric measurements were available for blood glucose, blood pressure, weight, and pulse oximetry. Results were sent via Bluetooth technology through double FDA approved off the shelf devices and transmitted to the CYTTA Connect dashboard. Access to the dashboard and ability to send care alerts were available to all members of the care coordination team, patients, and designated physicians/family members/caregivers.